DE3271647D1 - Polymeric diffusion matrix containing propranolol - Google Patents

Polymeric diffusion matrix containing propranolol

Info

Publication number
DE3271647D1
DE3271647D1 DE8282902505T DE3271647T DE3271647D1 DE 3271647 D1 DE3271647 D1 DE 3271647D1 DE 8282902505 T DE8282902505 T DE 8282902505T DE 3271647 T DE3271647 T DE 3271647T DE 3271647 D1 DE3271647 D1 DE 3271647D1
Authority
DE
Germany
Prior art keywords
propranolol
diffusion matrix
polymeric diffusion
matrix containing
containing propranolol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282902505T
Other languages
English (en)
Inventor
Alec Dell Keith
Wallace Snipes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3271647D1 publication Critical patent/DE3271647D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE8282902505T 1981-07-08 1982-07-08 Polymeric diffusion matrix containing propranolol Expired DE3271647D1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28132281A 1981-07-08 1981-07-08
US33738682A 1982-01-06 1982-01-06
US33825682A 1982-01-11 1982-01-11
PCT/US1982/000926 WO1983000092A1 (en) 1981-07-08 1982-07-08 Polymeric diffusion matrix containing propranolol

Publications (1)

Publication Number Publication Date
DE3271647D1 true DE3271647D1 (en) 1986-07-17

Family

ID=27403219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282902505T Expired DE3271647D1 (en) 1981-07-08 1982-07-08 Polymeric diffusion matrix containing propranolol

Country Status (5)

Country Link
EP (1) EP0082880B1 (de)
JP (1) JPS58501034A (de)
AT (1) ATE20311T1 (de)
DE (1) DE3271647D1 (de)
WO (1) WO1983000092A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
NZ220599A (en) * 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
JP2509585B2 (ja) * 1986-10-21 1996-06-19 帝國製薬株式会社 外用貼付剤
GB2236432B (en) * 1989-09-30 1994-06-29 Kyocera Corp Dielectric filter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2155658A (en) * 1936-01-08 1939-04-25 Chemische Forschungs Gmbh Surgical and medical preparations
US2160503A (en) * 1936-02-14 1939-05-30 Chemische Forschungs Gmbh Blood stancher
US2127896A (en) * 1936-08-13 1938-08-23 Vohrer Herbert Method of producing elastic objects from polyvinyl alcohols
US2693438A (en) * 1951-02-21 1954-11-02 Norwich Pharma Co Preformed, nonadherent films for application to open lesions
BE638231A (de) * 1962-03-16
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator

Also Published As

Publication number Publication date
EP0082880A4 (de) 1984-01-12
WO1983000092A1 (en) 1983-01-20
EP0082880A1 (de) 1983-07-06
JPS58501034A (ja) 1983-06-30
ATE20311T1 (de) 1986-06-15
EP0082880B1 (de) 1986-06-11

Similar Documents

Publication Publication Date Title
DE3071186D1 (en) Optically active 1,4-dihydropyridines, processes for their preparation and their use as medicaments
IL59063A (en) Polymeric diffusion matrix for release of pharmaceutical dosage
EP0508488A3 (de) Verwendung von Inositoltriphosphat zur Behandlung von mit Metallvergiftungen verbundenen Krankheiten
ZA9610864B (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
GB2053681B (en) Sustained release pharmaceutical composition
CA2203901A1 (en) Polymeric wound healing accelerators
DE3273501D1 (en) Continuous release pharmaceutical compositions
HUT43637A (en) Process for producing biologically active new materials and veterinary compositions containing them as active agents, and nematocide insecticide and acaricide compositions containing the above mentioned materials as active agents
EP0032927A4 (de) System zur kontrollierten freigabe einer biologisch aktiven substanz in einer körperflüssigkeit.
ZA91274B (en) Controlled absorption naproxen formulation for once-daily administration
AU567434B2 (en) A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
HUT41203A (en) Herbicide compositions containing 2-/2-comma above-substituted benzoyl/-1,3-cyclomexene-dione derivatives as active agents and process for producing the active agents
NO1997001I1 (no) 17<beta>-østradiol
JPS56103110A (en) Sustained release medicinal composition
DE3271647D1 (en) Polymeric diffusion matrix containing propranolol
ATE68686T1 (de) System zum freigeben von stoffen in der vagina.
JPS56500495A (de)
GB2089210A (en) Polymeric diffusion matrix for administration of drugs
GB2098867B (en) Sustained release pharmaceutical composition
DE3872808D1 (de) Pyrazolderivat und insektizide und mitizide zusammenstellung, das derivat als aktives agens enthaltend.
EP0294053A3 (en) Physiologically active agent for agricultural use
JPS5594316A (en) Diffusion matrix for medicine release
DE3263167D1 (en) Physiologically active substance fa-5859, its derivative; their production and antidiabetic agents containing said compounds
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
JPS57116071A (en) Adenine derivative, manufacture and medicinal composition containing same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee